Condition: Metastatic Castration Resistant Prostate Cancer · Sponsor: Atridia Pty Ltd.
To evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of 5041-103 in Subjects with Metastatic Castration-resistant Prostate Cancer.
This description comes directly from the study's public registry record.
Kathy You · +61 02 9299 0433 · kathyyou@atridia.com
Ravi Patel · +61 452 363 506 · ravi.patel@atridia.com
Always discuss trial participation with your own doctor first.
| GenesisCare North Shore (Oncology) | Sydney, New South Wales, Australia | Recruiting |
| Sydney Adventist Hospital | Sydney, New South Wales, Australia | Recruiting |
| Cancer Research SA | Adelaide, South Australia, Australia | Recruiting |
| Southern Oncology Clinical Research Unit | Adelaide, South Australia, Australia | Recruiting |
| Icon Cancer Centre South Brisbane | Brisbane, Australia | Recruiting |
| John Flynn Private Hospital | Brisbane, Australia | Recruiting |
| Eastern Health (Box Hill Hospital) | Melbourne, Australia | Recruiting |
| Linear Clinical Research Ltd | Perth, Australia | Recruiting |
| Macquarie University | Sydney, Australia | Recruiting |
| MUPharm Pty Limited trading as Macquarie University Hospital Pharmacy | Sydney, Australia | Recruiting |
| Illawarra Shoalhaven Local Health District (Wollongong Hospital) | Wollongong, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06830850